hdcc program

Immucision HDCC program provides human dendritic cell lines to the scientific community to enhance research in cancer immunotherapy

Cell line licensing process and selection of DC cell lines

Comprehensive Service Plan for Generating and Validating Human Dendritic Cell Lines

We provide NeoAntigen Immunogenicity Validation Platform Kit, NAIV-P2.1, which tests the immunogenicity of HLA-A2.1-restricted neoantigens